S&P 500   3,004.52 (+0.28%)
DOW   26,833.95 (+0.17%)
QQQ   192.22 (+0.19%)
AAPL   243.18 (+1.34%)
FB   186.15 (+2.09%)
MSFT   137.24 (+0.64%)
GOOGL   1,257.63 (+1.32%)
AMZN   1,762.17 (-0.20%)
CGC   21.68 (+2.51%)
NVDA   195.09 (-0.27%)
MU   44.66 (+0.00%)
BABA   169.92 (+0.02%)
GE   9.13 (+0.77%)
TSLA   254.68 (-0.35%)
AMD   31.36 (-0.48%)
T   37.74 (-1.13%)
F   9.21 (+1.54%)
ACB   3.68 (+2.79%)
PRI   125.80 (+0.00%)
BAC   31.43 (+0.74%)
GILD   66.58 (+1.09%)
DIS   131.13 (-0.96%)
S&P 500   3,004.52 (+0.28%)
DOW   26,833.95 (+0.17%)
QQQ   192.22 (+0.19%)
AAPL   243.18 (+1.34%)
FB   186.15 (+2.09%)
MSFT   137.24 (+0.64%)
GOOGL   1,257.63 (+1.32%)
AMZN   1,762.17 (-0.20%)
CGC   21.68 (+2.51%)
NVDA   195.09 (-0.27%)
MU   44.66 (+0.00%)
BABA   169.92 (+0.02%)
GE   9.13 (+0.77%)
TSLA   254.68 (-0.35%)
AMD   31.36 (-0.48%)
T   37.74 (-1.13%)
F   9.21 (+1.54%)
ACB   3.68 (+2.79%)
PRI   125.80 (+0.00%)
BAC   31.43 (+0.74%)
GILD   66.58 (+1.09%)
DIS   131.13 (-0.96%)
Log in

Misonix Stock Price, News & Analysis (NASDAQ:MSON)

$17.87
-0.01 (-0.06 %)
(As of 10/23/2019 04:00 PM ET)
Today's Range
$17.69
Now: $17.87
$18.13
50-Day Range
$16.52
MA: $18.47
$20.16
52-Week Range
$13.19
Now: $17.87
$27.54
Volume903 shs
Average Volume37,702 shs
Market Capitalization$172.45 million
P/E RatioN/A
Dividend YieldN/A
Beta0.35
Misonix, Inc, together with its subsidiaries, designs, develops, manufactures, and markets therapeutic ultrasonic medical devices in the United States, the Americas, Europe, Middle East, Asia Pacific, Africa, and internationally. The company offers BoneScalpel, an ultrasonic bone cutting and sculpting system for surgical procedures involving the precise cutting of bone while sparing soft tissue; SonaStar, a surgical aspirator that is used to emulsify and remove soft and hard tumors primarily in the neuro and general surgery field; and SonicOne, an ultrasonic cleansing and debridement system, which provides tissue specific debridement and cleansing of wounds and burns for the removal of devitalized tissue and fibrin deposits while sparing viable cells. Read More…

Industry, Sector and Symbol

Industry Laboratory apparatus & furniture
Sub-IndustryN/A
SectorComputer and Technology
Current SymbolNASDAQ:MSON
CUSIPN/A
Phone631-694-9555

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$38.85 million
Book Value$2.25 per share

Profitability

Net Income$-7,390,000.00

Miscellaneous

Employees118
Market Cap$172.45 million
Next Earnings Date11/14/2019 (Estimated)
OptionableNot Optionable

Receive MSON News and Ratings via Email

Sign-up to receive the latest news and ratings for MSON and its competitors with MarketBeat's FREE daily newsletter.


Misonix (NASDAQ:MSON) Frequently Asked Questions

What is Misonix's stock symbol?

Misonix trades on the NASDAQ under the ticker symbol "MSON."

How were Misonix's earnings last quarter?

Misonix, Inc. (NASDAQ:MSON) issued its quarterly earnings data on Wednesday, August, 14th. The medical equipment provider reported ($0.11) EPS for the quarter. The medical equipment provider had revenue of $9.75 million for the quarter. Misonix had a negative return on equity of 25.99% and a negative net margin of 19.01%. View Misonix's Earnings History.

When is Misonix's next earnings date?

Misonix is scheduled to release their next quarterly earnings announcement on Thursday, November 14th 2019. View Earnings Estimates for Misonix.

What price target have analysts set for MSON?

2 equities research analysts have issued twelve-month price objectives for Misonix's stock. Their predictions range from $27.00 to $30.00. On average, they anticipate Misonix's stock price to reach $28.50 in the next twelve months. This suggests a possible upside of 59.5% from the stock's current price. View Analyst Price Targets for Misonix.

What is the consensus analysts' recommendation for Misonix?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Misonix in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Misonix.

Has Misonix been receiving favorable news coverage?

News articles about MSON stock have been trending somewhat positive this week, InfoTrie reports. The research group identifies negative and positive news coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Misonix earned a media sentiment score of 2.0 on InfoTrie's scale. They also assigned news headlines about the medical equipment provider a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an impact on the company's share price in the near term. View News Stories for Misonix.

Are investors shorting Misonix?

Misonix saw a drop in short interest during the month of September. As of September 15th, there was short interest totalling 384,700 shares, a drop of 5.5% from the August 15th total of 406,900 shares. Based on an average daily trading volume, of 64,000 shares, the days-to-cover ratio is currently 6.0 days. Approximately 4.8% of the shares of the stock are sold short. View Misonix's Current Options Chain.

Who are some of Misonix's key competitors?

What other stocks do shareholders of Misonix own?

Who are Misonix's key executives?

Misonix's management team includes the folowing people:
  • Mr. Stavros George Vizirgianakis, Pres, CEO & Director (Age 49)
  • Mr. Joseph P. Dwyer, CFO, Treasurer & Sec. (Age 63)
  • Mr. Robert Scott Ludecker, Sr. VP of Global Sales & Marketing (Age 52)
  • Ms. Sharon W. Klugewicz, Chief Operating Officer (Age 51)
  • Mr. John J. Salerno, VP of Quality and Regulatory Affairs & Chief Compliance Officer (Age 64)

Who are Misonix's major shareholders?

Misonix's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include Essex Investment Management Co. LLC (0.96%), Ingalls & Snyder LLC (0.56%) and Meeder Asset Management Inc. (0.02%). Company insiders that own Misonix stock include Christopher H Wright, Joseph J Brennan, Joseph P Dwyer, Patrick A Mcbrayer, Sharon W Klugewicz and Thomas M Patton. View Institutional Ownership Trends for Misonix.

Which institutional investors are selling Misonix stock?

MSON stock was sold by a variety of institutional investors in the last quarter, including Essex Investment Management Co. LLC and Ingalls & Snyder LLC. Company insiders that have sold Misonix company stock in the last year include Christopher H Wright and Joseph J Brennan. View Insider Buying and Selling for Misonix.

Which institutional investors are buying Misonix stock?

MSON stock was bought by a variety of institutional investors in the last quarter, including Meeder Asset Management Inc.. Company insiders that have bought Misonix stock in the last two years include Joseph P Dwyer, Patrick A Mcbrayer, Sharon W Klugewicz and Thomas M Patton. View Insider Buying and Selling for Misonix.

How do I buy shares of Misonix?

Shares of MSON can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Misonix's stock price today?

One share of MSON stock can currently be purchased for approximately $17.87.

How big of a company is Misonix?

Misonix has a market capitalization of $172.45 million and generates $38.85 million in revenue each year. Misonix employs 118 workers across the globe.View Additional Information About Misonix.

What is Misonix's official website?

The official website for Misonix is http://www.misonix.com/.

How can I contact Misonix?

Misonix's mailing address is 1938 NEW HIGHWAY, FARMINGDALE NY, 11735. The medical equipment provider can be reached via phone at 631-694-9555.


MarketBeat Community Rating for Misonix (NASDAQ MSON)

Community Ranking:  2.2 out of 5 (star star)
Outperform Votes:  90 (Vote Outperform)
Underperform Votes:  110 (Vote Underperform)
Total Votes:  200
MarketBeat's community ratings are surveys of what our community members think about Misonix and other stocks. Vote "Outperform" if you believe MSON will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MSON will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 10/23/2019 by MarketBeat.com Staff

Featured Article: Quick Ratio

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel